Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.

First published in Diabetes, Obesity and Metabolism on 2014 May. Diabetes Obes Metab. 2014 May;16(5):467-77. doi: 10.1111/dom.12273. Epub 2014 Mar...
Read Article

Impact of impaired renal function on the pharmacokinetics of the antiepileptic drug lacosamide.

First published in Clinical Pharmacokinetics on 2013 Oct.Clin Pharmacokinet. 2013 Oct;52(10):897-906. doi: 10.1007/s40262-013-0080-7. Authors: Cawello W, Fuhr U, Hering U,...
Read Article